// App-Quantinova.ai

5049 : TERRAIN.

Researchers

Presenter

  • Simon Chowdhury

Principal Investigators

  • Axel Heidenreich

  • De Phung

  • Fong Wang

  • David Forer

  • Steve Van Os

  • Neal D. Shore

  • Arnauld Villers

  • Laurence Klotz

  • D. Robert Siemens

Medical Centers

  • Medication, Inc., San Francisco, CA

  • Department of Urology, Lille University, Lille, FranceUniversity Hospital, RWTH Aachen, Aachen, GermanyAstellas Pharma , Leiderdorp, Netherlands

  • University of Toronto, Toronto, ON, Canada

  • Medical Oncology Department, Guys and St. Thomas NHS Foundation Trust, London, United Kingdom

  • Astellas Pharma Global Development, Leiden, Netherlands

  • Medication, Inc., San Francisco, CA

  • Division of Cancer Care and Epidemiology, Queens University Cancer Research Institute, Kingston, ON, Canada

  • Carolina Urologic Research Center, Myrtle Beach, SC

Locations

  • United States

  • Canada

  • United Kingdom

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A